Stay updated on Clinical Trial: Olaparib + Abiraterone in Prostate Cancer
Sign up to get notified when there's something new on the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page.

Latest updates to the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page
- Check6 days agoChange DetectedA notice announces an NIH-wide terminology transition from “Artificial Intelligence” to “Super Intelligence” and points visitors to updates and FAQs.SummaryDifference0.5%

- Check13 days agoChange DetectedThe ClinicalTrials.gov site footer now identifies the platform as revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check20 days agoChange DetectedThe footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check41 days agoChange DetectedA new revision entry appears in the record history for v3.7.0, replacing the previous v3.6.6. This reflects an updated version of the page's documentation.SummaryDifference0.1%

- Check62 days agoChange DetectedA new version entry (version 26) was added on 2026-08-27 with an update to the Study Status. The page revision was updated to v3.6.6 on 2026-08-28.SummaryDifference0.4%

- Check83 days agoChange DetectedThe page history now shows a new site revision (v3.6.5) replacing the previous (v3.6.4), indicating a software update to the ClinicalTrials.gov history interface.SummaryDifference0.2%

Stay in the know with updates to Clinical Trial: Olaparib + Abiraterone in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page.